Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

SEROLOGICAL DETECTION OF ANTIBODIES TO HTLV-III IN SER PATIENTS WITH AIDS AND PRE-AIDS CONDITIONS

  • Read more about SEROLOGICAL DETECTION OF ANTIBODIES TO HTLV-III IN SER PATIENTS WITH AIDS AND PRE-AIDS CONDITIONS
The Netherlands
85902364.0
Filed on 1985-04-23

MONOCLONAL ANTIBODIES AGAINST NON SMALL CELL LUNG CANCER

  • Read more about MONOCLONAL ANTIBODIES AGAINST NON SMALL CELL LUNG CANCER
France
84303310.1
Filed on 1984-05-10

Detection of Non-A, Non-B Hepatitis Associated Antigen

  • Read more about Detection of Non-A, Non-B Hepatitis Associated Antigen
Japan
55-501402
Filed on 1980-05-21

Detection of Non-A, Non-B Hepatitis Associated Antigen

  • Read more about Detection of Non-A, Non-B Hepatitis Associated Antigen
Canada
413076
Filed on 1982-10-07

Detection of Non-A, Non-B Hepatitis Associated Antigen

  • Read more about Detection of Non-A, Non-B Hepatitis Associated Antigen
Canada
352378
Filed on 1980-05-21

IMPROVED PSEUDOMONAS EXOTOXINS OF LOW ANIMAL TOXICITY AND HIGH CYTOCIDAL ACTIVITY

  • Read more about IMPROVED PSEUDOMONAS EXOTOXINS OF LOW ANIMAL TOXICITY AND HIGH CYTOCIDAL ACTIVITY
Japan
80540/96
Filed on 1991-05-10

IMPROVED PSEUDOMONAS EXOTOXINS OF LOW ANIMAL TOXICITY AND HIGH CYTOCIDAL ACTIVITY

  • Read more about IMPROVED PSEUDOMONAS EXOTOXINS OF LOW ANIMAL TOXICITY AND HIGH CYTOCIDAL ACTIVITY
European Patent
91911177.3
Filed on 1991-05-10

ANTI-HYPERTENSIVE COMPOSITIONS OF SECONDARY AMINE-NITRIC OXIDE ADDUCTS AND USE THEREOF

  • Read more about ANTI-HYPERTENSIVE COMPOSITIONS OF SECONDARY AMINE-NITRIC OXIDE ADDUCTS AND USE THEREOF
Australia
65226/90
Filed on 1990-09-07

ANTIVIRAL COMPOSITIONS CONTAINING SULFOQUINOVOSYL GLYCEROL DERIVATIVES AND ANALOGS THEROF AND METHODS FOR USING SAME

  • Read more about ANTIVIRAL COMPOSITIONS CONTAINING SULFOQUINOVOSYL GLYCEROL DERIVATIVES AND ANALOGS THEROF AND METHODS FOR USING SAME
The Netherlands
90911686.5
Filed on 1990-08-03

Chemotherapeutic composition for AIDS

  • Read more about Chemotherapeutic composition for AIDS
Australia
37319/89
Filed on 1989-05-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1437
  • Page 1438
  • Page 1439
  • Page 1440
  • Page 1441
  • Page 1442
  • Page 1443
  • Page 1444
  • Page 1445
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health